EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Computer-aided drug discovery: historical foundations, practical AI tools, and emerging ethical considerations

Rebekah Clarke, Giuseppe Palazzo, Jiri Ruzicka, Salvatore Ferla, Marcella Bassetto

Frontiers in Pharmacology · 24.06.2026 · 17

DOI: 10.3389/fphar.2026.1866562 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 24.06.2026. Verfasst von Rebekah Clarke und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, Faculty of Medicine, Health and Life Science, Swansea University, Swansea, United Kingdom. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Computer-aided drug discovery (CADD) has become an integral component of modern drug development, supporting hit identification, lead optimisation, and candidate refinement across both academia and industry. Over 4 decades of methodological progress have contributed to the discovery or optimisation of several approved therapeutics, establishing CADD as a crucial element of drug research. In parallel, recent advances in artificial intelligence (AI) and machine learning (ML) have introduced a new generation of practical tools that offer improved predictive performance, accessible software implementations, and increasing integration into everyday drug discovery and pharmacology workflows. This review provides a concise historical overview of CADD, with an updated account of approved drugs and clinical-stage candidates whose discovery or optimisation has involved computational methods and highlights a curated set of contemporary AI and ML tools that are readily usable by non-specialists. In addition, we compile and analyse two comprehensive, practice-oriented resources: a collection of cloud-based virtual-screening platforms, and an extensive suite of freely accessible ADMET prediction tools, offering medicinal chemists a consolidated guide to open-source computational workflows. Finally, we discuss emerging ethical considerations, including data bias, transparency, computational costs, and the environmental impact of large-scale models, outlining responsible paths for the continued adoption of AI in drug discovery.

Schlagwörter

Stichwörter der Autor:innen

ADMET predictionartificial intelligencecomputational pharmacologycomputer-aided drug discoverymachine learningvirtual screening

Autor:innen und Institutionen

  • Medical School, Faculty of Medicine, Health and Life Science, Swansea University, Swansea, United Kingdom.
  • School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, United Kingdom.

Zitieren

APA

Clarke, R., Palazzo, G., Ruzicka, J., Ferla, S., & Bassetto, M. (2026). Computer-aided drug discovery: historical foundations, practical AI tools, and emerging ethical considerations. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1866562

Vancouver

Clarke R, Palazzo G, Ruzicka J, Ferla S, Bassetto M. Computer-aided drug discovery: historical foundations, practical AI tools, and emerging ethical considerations. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1866562

BibTeX
@article{Clarke2026,
  author = {Clarke, Rebekah and Palazzo, Giuseppe and Ruzicka, Jiri and Ferla, Salvatore and Bassetto, Marcella},
  title = {Computer-aided drug discovery: historical foundations, practical AI tools, and emerging ethical considerations},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1866562}
}
Kostenlos starten →